CurrentCardio
Get Weekly

Topic · page 36 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,401–1,440 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. Nat Med

    The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial

    Randomised controlled trial

  2. Eur J Heart Fail

    Characterizing Atrial Fibrillation in Patients with and Without Heart Failure Across the Ejection Fraction Spectrum: Incidence, Prevalence, and Treatment Strategies

    Cohort study

  3. Eur J Heart Fail

    Clonal Haematopoiesis is Associated with Major Adverse Cardiovascular Events in Patients with Hypertrophic Cardiomyopathy

    Cohort study

  4. JACC Heart Fail

    Early U.S. Heart Transplant Experience With Normothermic Regional Perfusion Following Donation After Circulatory Death

    Cohort study

  5. Eur J Heart Fail

    Status and Timing of Angiotensin Receptor–Neprilysin Inhibitor Implementation in Patients with Heart Failure and Reduced Ejection Fraction: Data from the Swedish Heart Failure Registry

    Cohort study

  6. Eur J Heart Fail

    Biomarker Profiles Associated with Reverse Ventricular Remodelling in Patients with Heart Failure and a Reduced Ejection Fraction: Insights from the Echocardiographic Substudy of the VICTORIA Trial

    Secondary analysis

  7. Eur J Heart Fail

    Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction: Size matters

    Cohort study

  8. Eur Heart J

    Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study

    Cohort study

  9. Eur J Heart Fail

    Changes in 6‐min walk test is an independent predictor of death in chronic heart failure with reduced ejection fraction

    Cohort study

  10. Eur J Heart Fail

    Efficacy and Safety of Hypertonic Saline Therapy in Ambulatory Patients with Heart Failure: The SALT-HF Trial

    Randomised controlled trial

  11. Eur J Heart Fail

    Predictors of the Efficacy of His Bundle Pacing in Patients with a Prolonged PR Interval: A Stratified Analysis of the HOPE-HF Randomized Controlled Trial

    Secondary analysis

  12. Eur J Heart Fail

    Catheter-Based Ablation to Improve Outcomes in Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction: Rationale and Design of the CABA-HFPEF-DZHK27 Trial

    Randomised controlled trial

  13. JACC Cardiovasc Imaging

    Dapagliflozin Effects on Cardiac Deformation in Heart Failure and Secondary Clinical Outcome

    Randomised controlled trial

  14. Eur J Heart Fail

    Effects of Dapagliflozin According to QRS Duration Across the Spectrum of Left Ventricular Ejection Fraction: An Analysis of DAPA-HF and DELIVER

    Secondary analysis

  15. Eur J Heart Fail

    Association of Baseline and Longitudinal Changes in Insulin-Like Growth Factor-Binding Protein-7 with the Risk of Incident Heart Failure: Data from the PREVEND Study

    Cohort study

  16. Eur J Heart Fail

    European Society of Cardiology Quality Indicators Update for the Care and Outcomes of Adults with Heart Failure. The Heart Failure Association of the ESC

    Guideline or statement

  17. Nat Med

    An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score

    Diagnostic or prognostic study

  18. JACC Cardiovasc Imaging

    Myocardial Characteristics, Cardiac Structure, and Cardiac Function in Systemic Light-Chain Amyloidosis

    Cohort study

  19. JACC Cardiovasc Imaging

    Prognostic Value of Left Ventricular 18F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis

    Cohort study

  20. JACC Cardiovasc Imaging

    2-Dimensional Echocardiographic Global Longitudinal Strain With Artificial Intelligence Using Open Data From a UK-Wide Collaborative

    Diagnostic or prognostic study

  21. JACC Cardiovasc Imaging

    Machine Learning in Hypertrophic Cardiomyopathy: Nonlinear Model From Clinical and CMR Features Predicting Cardiovascular Events

    Diagnostic or prognostic study

  22. Eur J Heart Fail

    Plasma Soluble Fms-Like Tyrosine Kinase-1, Placental Growth Factor, and Vascular Endothelial Growth Factor System Gene Variants as Predictors of Survival in Heart Failure

    Cohort study

  23. Eur J Heart Fail

    High Variability in Assays of Blood Markers of Collagen Turnover in Cardiovascular Disease: Implications for Research and Clinical Practice

    Meta-analysis

  24. Eur J Heart Fail

    Iron Deficiency and Supplementation in Patients with Heart Failure: Results from the IRON-HF International Survey

    Cross-sectional study

  25. Eur J Heart Fail

    Hypoalbuminaemia and Heart Failure: A Practical Review of Current Evidence

    Research article

  26. JACC Heart Fail

    Optimizing Triage of Ambulatory Patients With Advanced Heart Failure: 2-Year Outcomes From REVIVAL

    Cohort study

  27. JACC Heart Fail

    Distinct Comorbidity Clusters in Patients With Acute Heart Failure: Data From RELAX-AHF-2

    Secondary analysis

  28. JAMA Cardiol

    High Throughput Plasma Proteomics and Risk of Heart Failure and Frailty in Late Life

    Cohort study

  29. Circulation

    Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study

    Randomised controlled trial

  30. Eur J Prev Cardiol

    Deceived by the Fick principle: blood flow distribution in heart failure

    Mechanistic study

  31. Europace

    Clinical outcomes of catheter ablation for atrial fibrillation, atrial flutter, and atrial tachycardia in wild-type transthyretin amyloid cardiomyopathy: a proposed treatment strategy for catheter ablation in each arrhythmia

    Cohort study

  32. JACC Heart Fail

    Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients

    Randomised controlled trial

  33. JACC Heart Fail

    Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial

    Secondary analysis

  34. JACC Heart Fail

    2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF II

    Secondary analysis

  35. JACC Heart Fail

    Combining Loop and Thiazide Diuretics Across the Left Ventricular Ejection Fraction Spectrum: The CLOROTIC Trial

    Secondary analysis

  36. Eur J Heart Fail

    A Novel Controlled Metabolic Accelerator for the Treatment of Obesity-Related Heart Failure with Preserved Ejection Fraction: Rationale and Design of the Phase 2a HuMAIN Trial

    Trial design

  37. Eur J Heart Fail

    Cardiovascular-Kidney-Metabolic Overlap in Heart Failure with Preserved Ejection Fraction: Cardiac Structure and Function, Clinical Outcomes, and Response to Sacubitril/Valsartan in PARAGON-HF

    Secondary analysis

  38. Eur Heart J

    Management of cardiac sarcoidosis

    Guideline or statement

  39. Eur Heart J

    Intravenous iron therapy results in rapid and sustained rise in myocardial iron content through a novel pathway

    Cohort study

  40. Europace

    Understanding the incidence of atrial fibrillation and stroke in hypertrophic cardiomyopathy patients: insights from Danish nationwide registries

    Cohort study

All 1,928 Briefs in ExploreShowing Briefs 1,401–1,440 of 1,928, newest first